ArticleFrontiers in oncology2019

A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer.

Tomás Pascual et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.